Sponsor or institution
Clinical trials and research at Beijing Anzhen Hospital
As of November 12, 2026, Find a Trial lists 48 clinical trials run by Beijing Anzhen Hospital that are recruiting, in China. By phase: Phase 4 (3), Phase 2/3 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 48Clinical trials
- 1Country
Newest trials
All recruiting trials (48)
-
Atrial Shunt to Help Heart Failure With Reduced Ejection Fraction
This study tests whether an atrial shunt implanted after heart catheterization helps people with HFrEF when added to standard heart failure therapy.
-
Understanding risk factors for cognitive problems in people with coronary heart disease
In people with coronary heart disease, this study tests how metabolic factors and imaging features relate to cognitive impairment.
-
Yufeng Ningxin for High Blood Pressure in Adults
This study tests whether Yufeng Ningxin tablets can lower blood pressure in adults with essential hypertension compared with a placebo.
-
Femorofemoral versus left‑heart bypass for open thoracoabdominal aortic aneurysm repair
This will test whether femorofemoral bypass or left‑heart bypass works better for adults having open repair of a thoracoabdominal aortic aneurysm.
-
Cardiac ganglion catheter ablation to treat significant bradycardia
This trial will try catheter-based cardioneuroablation to see if ablating overactive cardiac ganglia reduces symptoms in adults with vagally-mediated symptomatic bradycardia compared with a sham procedure.
-
Non-contact smart mattress for continuous monitoring of heart rate, breathing, temperature, and posture
This project will test a non-contact smart mattress that continuously monitors heart rate, breathing, body temperature, and posture for adults hospitalized with cardiovascular disease.
-
Start CPAP After AF Ablation in OSA Patients
This study tests whether adding CPAP after AF ablation helps prevent atrial arrhythmia recurrence in adults with obstructive sleep apnea.
-
Transcatheter Edge-to-Edge Repair for Atrial Functional Mitral Regurgitation
This trial tests whether a transcatheter edge-to-edge repair device helps people with atrial functional mitral regurgitation who still have symptoms despite standard therapy.
-
Ablation to improve wellbeing and survival in people aged 80 and older with atrial fibrillation
This will see if catheter ablation, compared with a sham procedure, improves quality of life over six months for people aged 80 and older with symptomatic atrial fibrillation.
-
Composite-tip guiding catheter for transradial carotid stenting
This study tests a new composite-tip guiding catheter to see if it is safe and effective for transradial carotid artery stenting in adults.
-
Smartwatch-based program to improve heart health in adults with overweight and cardiometabolic risk
This project will test whether a smartwatch-led exercise, diet, and coaching program can help adults who are overweight or obese with prehypertension, prediabetes, or borderline high cholesterol improve their cardiovascular health.
-
Boosting the blood pressure benefit of CPAP for people with obstructive sleep apnea
This project will test whether CPAP lowers blood pressure more in some adults with obstructive sleep apnea and whether adding a short sleep medication for people who wake up at night improves that blood pressure effect.
-
ICE-guided cavotricuspid isthmus ablation with a circular pulsed-field catheter
This will see if a circular-shaped pulsed field ablation catheter, guided by intracardiac echocardiography, can safely and effectively achieve acute cavotricuspid isthmus ablation in adults with atrial fibrillation.
-
Digital remote care to optimize heart-failure medicines after hospital discharge
This trial will test whether a digital remote-management program helps adults recently hospitalized with HFrEF get their heart-failure medicines to recommended doses and avoid bad outcomes.
-
Helium-free magnetocardiography to guide care for stable coronary artery disease
This trial will test whether a helium-free magnetocardiography scan can help guide treatment decisions and improve outcomes for people aged 18–80 with stable coronary artery disease and 50–90% stenosis on coronary CTA.
-
Digital remote management to reduce ASCVD risk in high-risk adults
This trial tests whether a smartphone-based remote management platform can lower cardiovascular risk and improve blood pressure, glucose, and cholesterol control compared with usual care in adults at high risk for ASCVD.
-
Catheter ablation for AF after spontaneous intracranial hemorrhage: SAFER-AF
This study tests whether catheter ablation can offer better long-term outcomes than usual care for adults with atrial fibrillation who recently had a spontaneous intracranial hemorrhage.
-
Adding intravenous tirofiban after clot-busting treatment for patients who don't improve quickly from acute ischemic stroke
This trial will test whether giving the IV medicine tirofiban after standard clot-busting treatment helps adults with acute ischemic stroke who show poor improvement within an hour.
-
Balloon guide catheter plus filter protection during carotid artery stenting
This trial tests whether adding a balloon guide catheter to the usual distal filter during carotid artery stenting reduces debris-related brain injury in adults with symptomatic (≥50%) or asymptomatic (≥70%) carotid stenosis scheduled for stenting.
-
Arch-clamping with mild hypothermia for acute Type A aortic dissection.
This study will test whether using arch-clamping under mild hypothermia during total arch replacement with frozen elephant trunk reduces major complications in adults with acute Type A aortic dissection.
-
Ventricular Tachycardia in Structural Heart Disease: A Registry
This registry will track adults with structural heart disease who have VT or treated nonsustained VT to see how they are managed and what happens over time in real-world care in China.
-
Village-based program to manage chronic heart conditions in Qujiang older adults
This project will try a village-based program combining medicines, lifestyle support, education, and 7-day ECG monitoring for people aged 60+ in Qujiang with chronic heart conditions such as atrial fibrillation, high blood pressure, coronary artery disease, or heart failure.
-
Heart MRI scar analysis to predict sudden cardiac death after a heart attack
This study will see if detailed heart MRI scar pictures can predict out-of-hospital sudden cardiac death in people who have had a heart attack.
-
Marshall vein ethanol injection plus pulsed-field pulmonary vein isolation for paroxysmal atrial fibrillation
This trial will test whether injecting ethanol into the vein of Marshall in addition to pulsed-field pulmonary vein isolation reduces return of atrial fibrillation in adults with symptomatic paroxysmal AF undergoing their first ablation.
-
Ultrasound screening and combined treatment strategies for people with coronary and neck artery narrowing.
This project uses Doppler ultrasound to screen people with coronary artery disease scheduled for elective PCI to see if finding and managing neck artery narrowings together with heart procedures leads to better outcomes.
-
Balloon angioplasty vs stenting after residual intracranial narrowing in acute ischemic stroke
This trial tests whether balloon angioplasty is as good as stenting for patients with residual intracranial narrowing after initial stroke treatment.
-
Endovascular treatment plus tirofiban for strokes from intracranial atherosclerosis
This trial will see if giving tirofiban after endovascular clot removal helps people with acute large-vessel ischemic stroke caused by intracranial atherosclerosis.
-
Catheter Ablation for Atrial Fibrillation and Ventricular Tachycardia: A Chinese Registry
This registry follows adults with atrial fibrillation or ventricular tachycardia to see how well and safely catheter ablation works over time in real-world Chinese patients.
-
Outcomes and risk factors of different treatments for neuro-cardiac and post-cardiac surgery cerebrovascular disease
This study will look at adults with neuro-cardiac conditions or cerebrovascular problems after heart surgery to see which treatment approaches (simultaneous, staged, or conservative) are linked to better or worse outcomes.
-
Registry of adult patients with atrial fibrillation in China
This study is creating a long-term registry of adults with atrial fibrillation in China to see how different treatments work and how they affect patients' lives.
-
Plasma multi-omics prediction of left ventricular remodeling and major cardiac events after STEMI
This research tests whether blood multi-omics (proteins, metabolites, lipids, transcripts and immune markers) can predict left ventricular adverse remodeling (LVAR) and major adverse cardiovascular events (MACE) in adults after a first STEMI treated with primary PCI.
-
Catheter ablation for people with persistent atrial fibrillation and severe atrial functional mitral regurgitation
This will test whether adding catheter ablation to usual medicines helps adults with persistent atrial fibrillation and moderate-to-severe or severe atrial functional mitral regurgitation reduce valve leakage and improve symptoms and outcomes.
-
Early intra-aortic balloon pump (IABP) use after venoarterial ECMO for cardiogenic shock
This test will see if adding an intra-aortic balloon pump (IABP) soon after starting VA-ECMO helps adults with cardiogenic shock survive and recover better.
-
Stopping anticoagulants after successful atrial fibrillation ablation with intensive smartwatch monitoring
This trial will test whether adults 18–80 who are 60–365 days after a successful AF ablation and have been on a NOAC can safely stop their blood thinner while using frequent smartwatch and patch monitoring, aiming to lower bleeding without raising stroke or embolism risk.
-
Impact of lower vasopressor use on survival in patients with heart failure on ECMO
This study is testing if using less vasopressor medication can help adults with heart failure on ECMO survive better over 30 days.
-
Preventive stenting for vulnerable coronary plaques in ACS patients
This trial will test whether adding a preventive percutaneous intervention to optimal medical therapy helps people with acute coronary syndrome who have non-flow-limiting vulnerable coronary plaques.
-
AI-driven 7-day single-lead ECG patch monitoring to detect new atrial fibrillation in older adults
This project will test whether AI-read 7-day single-lead ECG patches can find new atrial fibrillation in people aged 60 and older in rural China better than routine 12-lead ECG screening.
-
Early versus later corrective surgery for newborns with Tetralogy of Fallot.
This trial will test whether doing corrective heart surgery within the first 28 days or waiting until 3–6 months leads to better outcomes for newborns with Tetralogy of Fallot.
-
Integrated prenatal and postnatal treatment for newborns with critical congenital heart disease
This study is testing a new approach that combines care before and after birth for newborns with serious heart defects to see if it can improve their treatment and recovery.
-
Registry study on the life cycle of patients with congenital heart disease
This study looks at how congenital heart disease affects patients in China from pregnancy through their entire lives to see how to improve their care and treatment.
-
Nafamostat mesilate versus heparin for anticoagulation in ECMO after cardiac surgery
This study will test whether nafamostat mesilate works better than unfractionated heparin for anticoagulation in adults on ECMO after cardiac surgery.
-
Bivalirudin versus heparin for blood thinning during ECMO
This trial tests whether bivalirudin keeps anticoagulation closer to target and reduces clotting or bleeding compared with standard heparin in adults on VA- or VV-ECMO.
-
Comparing standby and prophylactic ECMO during high-risk heart procedures
This study is testing whether using standby ECMO instead of routine ECMO can help patients with serious heart issues have better outcomes during high-risk heart procedures.
-
Using low-dose colchicine to treat acute coronary syndromes
This study tests if adding low-dose colchicine to standard treatment can help people with acute coronary syndromes avoid serious heart problems.
-
Model for predicting causes of chest pain
This study is trying to create a tool that helps doctors better understand the causes of chest pain in patients so they can provide the right treatment more quickly.
-
Registry of current care for patients with coronary artery disease
This study looks at how patients with coronary artery disease are currently being treated in hospitals to see what works well and what could be improved.
-
Using PCSK9 inhibitors to treat calcific aortic valve stenosis
This study is testing if adding a new type of cholesterol-lowering medication to the treatment of adults with calcific aortic stenosis can help slow down the disease compared to just using standard statins.
-
Registry of extracorporeal life support cases in China
This study collects information on patients using extracorporeal life support (ECLS) in China to see how well it helps with heart and lung problems over time.
Quick answers
How many clinical trials run by Beijing Anzhen Hospital are recruiting right now?
48, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 3, Phase 2/3: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.